Mycophenolate Mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: four years of experience

By Basara N.   Kiehl M.G.   Blau W.   Romer E.   Bischoff M.   Schmetzer B.   Kirsten D.   Gunzelmann S.   Fauser A.A.  

Transplantation Proceedings, Vol. 33, Iss. 3, 2001-05 ,pp. : 2121-2123

Elsevier

Access to resources Recommend Favorite

Safety and efficacy of mycophenolate mofetil for prophylaxis in Asian renal transplant recipients

By Suhail S.M.   Vathsala A.   Lou H.X.   Woo K.T.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 1757-1758

Elsevier

Access to resources Recommend Favorite

Efficacy and safety of daclizumab induction for primary kidney transplant recipients in combination with tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression

By Ciancio G.   Burke G.W.   Suzart K.   Vaidya A.   Roth D.   Kupin W.   Mattiazzi A.   Rosen A.   Esquenazi V.   Miller J.  

Transplantation Proceedings, Vol. 35, Iss. 2, 2003-03 ,pp. : 873-874

Elsevier

Access to resources Recommend Favorite

A prospective study comparing safety and efficacy of mycophenolate mofetil versus azathioprine in primary liver transplant recipients

By Fischer L.   Sterneck M.   Gahlemann C.G.   Malago M.   Rogiers X.   Broelsch C.E.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 2125-2127

Elsevier

Access to resources Recommend Favorite

Drug fever caused by mycophenolate mofetil in a renal transplant recipient-a case report

By Chueh S.-C.   Hong J.-C.   Huang C.-Y.   Lai M.-K.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 1925-1926

Elsevier

Access to resources Recommend Favorite